Roles of heat shock transcriptional factor 1 in cell proliferation independent of the heat shock response
Roles of heat shock transcriptional factor 1 in cell proliferation independent of the heat shock response
批准号:
10796280
负责人:
Jian Li
金额:
$4.49万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2020
资助国家:
美国
项目状态:
未结题
起止时间:
2020-09-02 至 2025-08-31
关键词:
Abnormal CellAddressAnimal ModelAnimalsCRISPR screenCaenorhabditis elegansCancer cell lineCell Cycle ProgressionCell NucleusCell ProliferationCell modelCellsCoupledCytosolDevelopmentDiseaseEnergy MetabolismFutureGene ExpressionGeneticGenetic TranscriptionGerm CellsHealthHeat-Shock ResponseInsulin-Like Growth Factor IKnowledgeLongevityMalignant NeoplasmsMissionModelingNematodaNucleosomesPIK3CG genePathologicPathway interactionsPhysiologicalPhysiological ProcessesPhysiologyPlayProliferatingProteinsRegulationRegulatory PathwayRegulonReproductionResearchRoleSignal TransductionSpecific qualifier valueStressSystemTherapeuticcancer cellcell typecopinggene drive systemheat shock transcription factorinsightprogramsprostate cancer cellproteostasisproteotoxicityresponsestem cell proliferationtooltranscriptome
中文摘要
摘要:热休克转录因子1(HSF 1)在细胞蛋白中起着重要作用
体内平衡(蛋白质平衡),并精确调节有机体的健康。HSF 1被激活,
蛋白质毒性应激在胞质溶胶和细胞核,并诱导保守的保护性反应
这就是所谓的热休克反应(HSR)。HSF 1也在特定的生理条件下被激活
调节发育、生殖、寿命和能量代谢。相反,异常
HSF 1的激活支持恶性肿瘤。虽然转录组和调控机制,
HSR中的HSF 1已被广泛研究,对于HSR中的HSF 1存在显著的知识空白。
HSF 1在生理上的程序性激活和疾病中的HSF 1失调。具体地说,
目前还不清楚:1>为什么HSF 1对某些细胞类型或细胞状态是必需的,
2>什么机制决定HSF 1的调节子和活动,
这些生理和病理条件。我的实验室建立了动物和细胞模型
来解决这些问题。以线虫C.作为一个模型和遗传工具,
我们新开发的,我们发现HSF 1是需要在生殖系祖细胞
以与HSR解偶联的方式增殖,这一必要条件由IGF-1/PI 3 K决定
发信号。我们将探讨IGF-1/PI 3 K通路如何调节生殖细胞中的HSF 1功能
通过细胞自主和非自主机制。与此同时,我们使用癌细胞系
为了了解HSF 1在异常细胞增殖中的作用,
已知HSF 1与HSR不同。我们最近已经确定了上位相互作用,
HSF 1在前列腺癌细胞中通过CRISPR筛选的增殖和存活。指导
因此,我们将研究HSF 1在细胞周期进程中的作用以及HSF 1在细胞周期中的调节作用。
复制偶联核小体组装因子CHAF 1B。通过这些研究,我们希望
揭示HSF 1的上下文相关需求,并确定指定
HSF 1在生殖系发育和不受控制的癌症中的独特转录程序
细胞增殖从那些典型的HSR。我们的研究将建立一个框架,
HSF 1在其他生理过程中的未来研究,并阐明潜在的治疗方法
针对癌症中HSF 1的特异性调节途径的策略。
英文摘要
Abstract: The heat shock transcriptional factor 1 (HSF1) plays central roles in cellular protein
homeostasis (proteostasis) and is precisely regulated for organismal health. HSF1 is activated by
proteotoxic stresses in the cytosol and nucleus, and induces the conserved protective response
called the heat shock response (HSR). HSF1 is also activated in specific physiological conditions
to regulate development, reproduction, longevity and energy metabolism. Conversely, aberrant
activation of HSF1 supports malignancy. While the transcriptome and regulatory mechanisms for
HSF1 in the HSR have been extensively studied, significant knowledge gaps exist for
programmed activation of HSF1 in physiology and dysregulation of HSF1 in diseases. Specifically,
it is poorly understood: 1> why HSF1 is essential for certain cell types or cellular states and
dispensable for others, and 2> what mechanisms determine HSF1’s regulons and activities in
those physiological and pathological conditions. My lab has established animal and cell models
to address these questions. Taking the nematode C. elegans as a model and the genetic tools
we newly developed, we have found that HSF1 is required in the germline for progenitor cell
proliferation in a manner uncoupled from the HSR, and this requisite is dictated by IGF-1/PI3K
signaling. We will explore how the IGF-1/PI3K pathway regulates HSF1 functions in germ cells
by cell-autonomous and non-autonomous mechanisms. Meanwhile, we are using cancer cell lines
to understand HSF1’s roles in abnormal cell proliferation, where the transcriptional program of
HSF1 is known to be distinct from the HSR. We have recently identified epistatic interactors of
HSF1 in proliferation and survival through CRISPR screens in prostate cancer cells. Guided by
the results, we will study the roles of HSF1 in cell-cycle progression and its regulation by the
replication-coupled nucleosome assembly factor CHAF1B. Through these studies, we expect to
uncover the context-dependent requirements for HSF1 and identify the mechanisms that specify
the unique transcriptional programs of HSF1 in germline development and uncontrolled cancer
cell proliferation from those of the canonical HSR. Our research will establish a framework for
future studies on HSF1 in other physiological processes and shed light on potential therapeutic
strategies that target the specific regulatory pathways of HSF1 in cancer.
期刊论文(4)
专著(0)
科研奖励(0)
会议论文
DOI:
10.1042/bst20220616
发表时间:
2023-04-26
期刊:
Biochemical Society transactions
影响因子:
3.9
作者:
[]
通讯作者:
DOI:
10.3389/fragi.2022.899744
发表时间:
2022
期刊:
FRONTIERS IN AGING
影响因子:
--
作者:
[Morphis, Allison C., Edwards, Stacey L., Erdenebat, Purevsuren, Kumar, Lalit, Li, Jian]
通讯作者:
Li, Jian
DOI:
10.1016/j.celrep.2021.109623
发表时间:
2021-08-31
期刊:
Cell reports
影响因子:
8.8
作者:
[Edwards SL, Erdenebat P, Morphis AC, Kumar L, Wang L, Chamera T, Georgescu C, Wren JD, Li J]
通讯作者:
Li J
Do long working hours increase the risk of cardiovascular disease mortality? Evidence from the U.S. National Health Interview Survey 1997-2015
-
批准号:10509317
-
项目类别:
-
资助金额:$19.56万
-
财政年份:2023
-
负责人:Jian Li
-
依托单位:
Towards the Translation of Synergistic Phage-Polymyxin Combination Therapy against Pandrug-resistant Klebsiella pneumoniae: A Systems Approach
-
批准号:10470088
-
项目类别:
-
资助金额:$13.72万
-
财政年份:2021
-
负责人:Jian Li
-
依托单位:
Roles of heat shock transcriptional factor 1 in cell proliferation independent of the heat shock response
-
批准号:10699046
-
项目类别:
-
资助金额:$41.0万
-
财政年份:2020
-
负责人:Jian Li
-
依托单位:
Roles of heat shock transcriptional factor 1 in cell proliferation independent of the heat shock response
-
批准号:10701882
-
项目类别:
-
资助金额:$41.0万
-
财政年份:2020
-
负责人:Jian Li
-
依托单位:
Roles of heat shock transcriptional factor 1 in cell proliferation independent of the heat shock response
-
批准号:10251924
-
项目类别:
-
资助金额:$43.7万
-
财政年份:2020
-
负责人:Jian Li
-
依托单位:
Roles of heat shock transcriptional factor 1 in cell proliferation independent of the heat shock response
-
批准号:10028798
-
项目类别:
-
资助金额:$43.7万
-
财政年份:2020
-
负责人:Jian Li
-
依托单位:
Advancing innovative therapies against pandrug-resistant Gram-negative superbugs
-
批准号:10189507
-
项目类别:
-
资助金额:$64.62万
-
财政年份:2019
-
负责人:Jian Li
-
依托单位:
Advancing innovative therapies against pandrug-resistant Gram-negative superbugs
-
批准号:10641847
-
项目类别:
-
资助金额:$64.62万
-
财政年份:2019
-
负责人:Jian Li
-
依托单位:
Advancing innovative therapies against pandrug-resistant Gram-negative superbugs
-
批准号:10441316
-
项目类别:
-
资助金额:$63.95万
-
财政年份:2019
-
负责人:Jian Li
-
依托单位:
Targeting the Urgent Need for New Antibiotics against Gram-negative ‘Superbugs’
-
批准号:10219081
-
项目类别:
-
资助金额:$84.05万
-
财政年份:2017
-
负责人:Jian Li
-
依托单位:
Combating Deadly Gram-negative Lung Infections: An Inhalation and Systems Approach
-
批准号:9366827
-
项目类别:
-
资助金额:$65.03万
-
财政年份:2017
-
负责人:Jian Li
-
依托单位:
Targeting the Urgent Need for New Antibiotics against Gram-negative ‘Superbugs’
-
批准号:9533994
-
项目类别:
-
资助金额:$79.38万
-
财政年份:2017
-
负责人:Jian Li
-
依托单位:
Combating Deadly Gram-negative Lung Infections: An Inhalation and Systems Approach
-
批准号:9980288
-
项目类别:
-
资助金额:$57.31万
-
财政年份:2017
-
负责人:Jian Li
-
依托单位:
Targeting the Urgent Need for New Antibiotics against Gram-negative ‘Superbugs’
-
批准号:9361074
-
项目类别:
-
资助金额:$105.98万
-
财政年份:2017
-
负责人:Jian Li
-
依托单位:
Novel PK/PD Strategies for Polymyxin Combinations against Gram-negative Superbugs
-
批准号:8709383
-
项目类别:
-
资助金额:$82.5万
-
财政年份:2014
-
负责人:Jian Li
-
依托单位:
Novel PK/PD Strategies for Polymyxin Combinations against Gram-negative Superbugs
-
批准号:9243982
-
项目类别:
-
资助金额:$85.73万
-
财政年份:2014
-
负责人:Jian Li
-
依托单位:
Novel PK/PD Strategies for Polymyxin Combinations against Gram-negative Superbugs
-
批准号:9034546
-
项目类别:
-
资助金额:$92.89万
-
财政年份:2014
-
负责人:Jian Li
-
依托单位:
New Tricks for 'Old' Drugs: PK/PD of Polymyxin Nonantibiotic Combinations
-
批准号:8708238
-
项目类别:
-
资助金额:$90.58万
-
财政年份:2014
-
负责人:Jian Li
-
依托单位:
Novel PK/PD Strategies for Polymyxin Combinations against Gram-negative Superbugs
-
批准号:8826683
-
项目类别:
-
资助金额:$90.26万
-
财政年份:2014
-
负责人:Jian Li
-
依托单位:
New Tricks for 'Old' Drugs: PK/PD of Polymyxin Nonantibiotic Combinations
-
批准号:9245624
-
项目类别:
-
资助金额:$85.57万
-
财政年份:2014
-
负责人:Jian Li
-
依托单位:
海外基金